COVID-19: DCGI Clears India's Indigenous MRNA Vaccine For Phase 2/3 Clinical Trials

[email protected]29 Sep, 2021News

DGCI gave a green nod to Gennova Biopharmaceuticals Ltd's COVID-19 vaccine. This is India's first indigenously developed mRNA vaccine. The Gennova Biopharmaceuticals is a part of the Emcure group of companies and is based in Pune. The biotechnology company has been working on the nation?s first mRNA-based Covid-19 vaccine, since last year and has cleared the safety protocols in the first phase of trials.